dm+d
420155008
Articles
How should intravenous (IV) potassium chloride be administered in adults?
20 September 2020
Potassium administration via the intravenous route should only be used when the oral or enteral route is not available or will not achieve the required…Medicine Compliance Aid Stability
Sando-K
Alturix Limited
Alturix Limited
Sando-K
Tablets efferverscent 12mmol K+
R1 · Red 1 Stability data indicates that the drug is not suitable for CAs.
Unsuitable
Contains dessicant in pack.
23 November 2022
Slow-K
Alturix Limited
Alturix Limited
Slow-K
Tablets m/r 8mmol K+ (600MG)
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Keep container tightly closed.
23 November 2022
Lactation Safety Information
Oral / Parenteral
Oral / Parenteral
31 July 2020